Lido Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.8K | Hold |
12,875
| – | – | ﹤0.01% | 1415 |
|
|
2025
Q1 | $59.1K | Hold |
12,875
| – | – | ﹤0.01% | 1336 |
|
|
2024
Q4 | $61.7K | Buy |
12,875
+1,850
| +17% | +$8.86K | ﹤0.01% | 1301 |
|
|
2024
Q3 | $51.7K | Buy |
11,025
+1,000
| +10% | +$4.69K | ﹤0.01% | 1243 |
|
|
2024
Q2 | $56.6K | Hold |
10,025
| – | – | ﹤0.01% | 1197 |
|
|
2024
Q1 | $41.2K | Hold |
10,025
| – | – | ﹤0.01% | 1193 |
|
|
2023
Q4 | $42.3K | Buy |
10,025
+25
| +0.3% | +$106 | ﹤0.01% | 1151 |
|
|
2023
Q3 | $43.2K | Buy |
+10,000
| New | +$43.2K | ﹤0.01% | 1005 |
|